Furthermore, aptamers targeting cancer-specific proteins, such as vascular endothelial growth factor (VEGF) [52], pigpen [53], prostate-specific membrane antigen (PSMA) [54], and receptor tyrosine kinase (RTK) [55], have been developed and studied. Here, FOLH1 is linked to cancer.